EP2931897

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP13814362A
Filing Date
Dec 12, 2013
Status
Granted And Under Opposition
Sep 29, 2017
Grant Date
Nov 1, 2017
External Links
Slate, Register

Biblio Summary

The patent EP2931897B1 was granted on Nov 1, 2017 by Massachusetts Institute Of Technology The patent is currently Granted And Under Opposition.

The table below shows 6 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CRISPR THERAPEUTICS AGAug 1, 2018ADMISSIBLE
MATHYS & SQUIRE LLPJul 26, 2018ADMISSIBLE
CARIBOU BIOSCIENCES, INC.Apr 12, 2018ADMISSIBLE
COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBMar 29, 2018WITHDRAWN
PATENT BOUTIQUE LLPJan 8, 2018ADMISSIBLE
SCHLICH, GEORGE WILLIAMNov 6, 2017ADMISSIBLE

The table below shows the patents of Massachusetts Institute Of Technology that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3294873Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin ReinductionSep 18, 20241
EP3604532Novel Crispr Enzymes And SystemsMay 1, 20241
EP3237615Crispr Having Or Associated With Destabilization DomainsJul 26, 20232

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.